Clinical Trials | February 13, 2024
Lord's Mark Industries files patent for bio-chemistry reagents; Targets revenue of Rs. 200 Cr
These re-agent and diagnostic test kits come with 99.7% accuracy
These re-agent and diagnostic test kits come with 99.7% accuracy
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Acute therapies continue to report strong growth compared to chronic ones.
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
Subscribe To Our Newsletter & Stay Updated
